Loading organizations...
Berkeley, California-based Decibel Bio is an agricultural biotechnology company developing a proprietary platform to read and write the plant epigenome for creating crop varieties with enhanced yield, efficiency, and resilience. The organization engineers "spray-on" epigenetic instructions that enable farmers to adjust plant traits, such as drought tolerance, in real-time during the growing season without introducing new genetic material. Operating with a specialized team of approximately 10 employees, including PhDs in synthetic biology and data science, the enterprise recently emerged from stealth mode after securing a $12 million oversubscribed financing round. This capital will advance their platform development and commercial partnerships alongside strategic backing from notable investors including Breakthrough Energy Ventures, Future Ventures, Bayer, and Syngenta. Conceived from technology originally developed at Sound Agriculture, Decibel Bio was officially founded in 2025 by Travis Bayer.
Decibel Bio has raised $12.0M across 1 funding round.
Decibel Bio has raised $12.0M in total across 1 funding round.
# Decibel Bio: Epigenetic Crop Programming for Real-Time Agricultural Adaptation
Decibel Bio is a plant biotechnology company that develops epigenetic reprogramming technology to enhance crop traits in real time, without altering plant DNA.[1][2] The company's platform allows farmers to fine-tune gene expression during the growing season, enabling dynamic adjustments to yield, drought tolerance, heat resistance, and other agronomic traits based on environmental conditions as they unfold.[1]
The company serves American farmers and agricultural partners by solving a fundamental timing problem: traditional crop breeding and genetic modification require trait decisions months in advance of planting, while weather and market conditions remain unpredictable.[5] Decibel's approach decouples trait selection from seed production, enabling farmers to "download" traits in-season through foliar sprays or seed treatments.[5] The company claims its platform can bring enhanced crops to market 100x faster than genetic technology or conventional breeding.[5]
Decibel Bio emerged from stealth in March 2025 with a $12 million Series A funding round led by Breakthrough Energy Ventures and Future Ventures, with participation from agricultural giants Bayer and Syngenta.[2] The founding team—experts in synthetic biology, epigenomics, plant physiology, and engineering—conceived and developed the platform at Sound Agriculture, a leader in climate-friendly agriculture.[1][2]
CEO and founder Travis Bayer frames the company's mission around a conceptual shift: "Epigenetics is the software of the plant, controlling when and where genes are expressed. Reprogramming the epigenome is a new frontier beyond genomics and gene editing."[2] This positioning reflects a deliberate move beyond the gene-editing paradigm that has dominated agricultural biotechnology, targeting instead the regulatory layer that controls gene expression without introducing new genetic material.
Decibel Bio operates at the intersection of climate adaptation, agricultural productivity, and biotechnology innovation. The company rides several converging trends:
Climate Volatility: Increasingly unpredictable weather patterns make static crop traits obsolete. Farmers need dynamic tools to respond to seasonal variation—a problem that traditional breeding cannot solve at the required speed.
Epigenomics Maturation: The field of plant epigenetics has historically lacked scalable tools and foundational data. Decibel's combination of sequencing technology and machine learning addresses this gap, making epigenetic engineering commercially viable for the first time.
Alternative to Gene Editing: As CRISPR and gene-editing technologies face regulatory scrutiny and consumer skepticism in some markets, epigenetic reprogramming offers a pathway to trait enhancement that avoids genetic modification entirely—a significant regulatory and market advantage.
Agricultural Consolidation: The involvement of Bayer and Syngenta signals that incumbent seed companies recognize epigenetics as a strategic frontier. Decibel's partnerships position it as a technology provider to the global agricultural supply chain rather than a direct competitor.
Decibel Bio addresses a genuine bottleneck in modern agriculture: the lag between trait development and farmer need. By decoupling trait selection from seed production, the company enables a fundamentally more responsive agricultural system—one where crops can be upgraded mid-season to match environmental realities.
The company's trajectory will depend on three factors: regulatory approval for epigenetic treatments (which remains uncertain), farmer adoption (requiring proof of agronomic benefit and ease of use), and scalability of manufacturing spray and seed treatments at commercial volumes. The backing of Breakthrough Energy Ventures and major seed companies suggests confidence in the technology's potential, but the path from proof-of-concept to widespread field deployment remains unproven.
If successful, Decibel could reshape how the agricultural industry thinks about crop improvement—shifting from static, pre-season decisions to dynamic, responsive trait management. This would represent a meaningful evolution in how humanity adapts food production to climate change and market volatility.
Decibel Bio has raised $12.0M in total across 1 funding round.
Decibel Bio's investors include Breakthrough Energy Ventures, Congruent Ventures, Drive Capital, Future Ventures, Microsoft, The Engine.
Decibel Bio has raised $12.0M across 1 funding round. Most recently, it raised $12.0M Series U in March 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2025 | $12M Series U | — | Breakthrough Energy Ventures, Congruent Ventures, Drive Capital, Future Ventures, Microsoft, The Engine | Announced |
